Wilhelmi G, Faust R
Pharmacology. 1976;14(4):289-96. doi: 10.1159/000136607.
Histological studies in male C57 black mice revealed a high incidence (39-61%) of osteo-arthrotic changes in the knee joint from about the 17th month of life. In animals of the same strain aged 15 1/2 months the incidence was only 19%. The incidence of gonarthroses in 16-month-old female mice was considerably lower (4%). In male mice aged 17-20 months, the oral administration of tribenoside in doses of 500 and 1,200 mg/kg weekly led to a significant (p less than 0.05) reduction in the overall arthrotic involvement. A possible relation between the effect of tribenoside and other anti-inflammatory agents on osteo-arthroses in the mouse and their influence on mucopolysaccharide metabolism in connective tissue is discussed. The incidence of the formation of gaps in the epiphyseal growth zones and of osteoporosis of the femur and tibia in the same strain increases distinctly with advancing age. Except in animals treated with the highest dosage tested, in which there was a significant decrease in the development of osteoporosis, tribenoside in the range of doses used had no influence on these skeletal changes.
对雄性C57黑鼠的组织学研究显示,从大约17月龄开始,膝关节骨关节炎改变的发生率很高(39%-61%)。在15.5月龄的同品系动物中,发生率仅为19%。16月龄雌性小鼠膝关节炎的发生率要低得多(4%)。在17-20月龄的雄性小鼠中,每周口服500和1200mg/kg剂量的曲克芦丁,可使关节病变的总体程度显著降低(p<0.05)。文中讨论了曲克芦丁与其他抗炎药对小鼠骨关节炎的作用及其对结缔组织中粘多糖代谢的影响之间可能存在的关系。同一品系中,骨骺生长区出现间隙以及股骨和胫骨骨质疏松的发生率随年龄增长而明显增加。在所测试的最高剂量组动物中,骨质疏松的发展显著减少,除此之外,所用剂量范围内的曲克芦丁对这些骨骼变化没有影响。